The impact of surgical technique on the results of liver transplantation in patients with hepatocellular carcinoma

Annals of Transplantation

Volumn 18, Issue 1, 2013, Pages 448-459

  Grat, Michał ^a   Kornasiewicz, Oskar ^a   Lewandowski, Zbigniew ^a   Skalski, Michał ^a   Zieniewicz, Krzysztof ^a   Paczek, Leszek ^a   Krawczyk, Marek ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Hepatocellular carcinoma; Liver transplantation; Neoplasm recurrence; Outcomes; Piggyback technique; Surgical technique

Indexed keywords

ALPHA FETOPROTEIN; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DEATH; ERYTHROCYTE TRANSFUSION; FEMALE; HEPATIC ARTERY THROMBOSIS; HUMAN; ISCHEMIA; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LYMPHOCELE; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PIGGYBACK PIGGYBACK; PLASMA TRANSFUSION; PRIMARY GRAFT DYSFUNCTION; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SEPSIS; SURGICAL PIGGYBACK;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84887225309     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: 10.12659/AOT.884005     Document Type: Article

References (53)

1. Tzakis A, Todo S, Starzl TE: Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg, 1989; 210: 649-52
2. Hesse UJ, Berrevoet F, Troisi R et al: Hepato-venous reconstruction in orthotopic liver transplantation with preservation of the recipients inferior vena cava and veno-venous bypass. Langenbecks Arch Surg, 2000; 385: 350-56
3. Margarit C, Lázaro JL, Balsells J et al: Recipient hepatectomy with preservation of inferior vena cava reduces the need for veno-venous bypass in liver transplantation. Transpl Int, 1994; 7: S152-54
4. Miyamoto S, Polak WG, Geuken E et al: Liver transplantation with preservation of the inferior vena cava. A comparison of conventional and piggyback techniques in adults. Clin Transplant, 2004; 18: 686-93
5. Sakai T, Matsusaki T, Marsh JW et al: Comparison of surgical methods in liver transplantation: retrohepatic caval resection with venovenous bypass (VVB) versus piggyback (PB) with VVB versus PB without VVB. Transpl Int, 2010; 23: 1247-58
6. Reddy KS, Johnston TD, Putnam LA et al: Piggyback technique and selective use of veno-venous bypass in adult orthotopic liver transplantation. Clin Transplant, 2000; 14: 370-74
7. Busque S, Esquivel CO, Concepcion W, So SK: Experience with the piggyback technique without caval occlusion in adult orthotopic liver transplantation. Transplantation, 1998; 65: 77-82
8. González FX, García-Valdecasas JC, Grande L et al: Vena cava vascular reconstruction during orthotopic liver transplantation: a comparative study. Liver Transpl Surg, 1998; 4: 133-40
9. Lerut JP, Molle G, Donataccio M et al: Cavocaval liver transplantation without venovenous bypass and without temporary portocaval shunting: the ideal technique for adult liver grafting? Transpl Int, 1997; 10: 171-79
10. Stieber AC: One surgeon's experience with the piggyback versus the standard technique in orthotopic liver transplantation: is one better than the other? Hepatogastroenterology, 1995; 42: 403-5
11. Khan S, Silva MA, Tan YM et al: Conventional versus piggyback technique of caval implantation; without extra-corporeal veno-venous bypass. A comparative study. Transpl Int, 2006; 19: 795-801
12. Hosein Shokouh-Amiri M, Osama Gaber A, Bagous WA et al: Choice of surgical technique influences perioperative outcomes in liver transplantation. Ann Surg, 2000; 231: 814-23
13. Jovine E, Mazziotti A, Grazi GL et al: Piggy-back versus conventional technique in liver transplantation: report of a randomized trial. Transpl Int, 1997; 10: 109-12
14. Cabezuelo JB, Ramirez P, Acosta F et al: Does the standard vs piggyback surgical technique affect the development of early acute renal failure after orthotopic liver transplantation? Transplant Proc, 2003; 35: 1913-14
15. Barshes NR, Lee T, Kiliç M, Goss JA: Reconstruction of the hepatic venous outflow in piggyback liver transplantation. Exp Clin Transplant, 2004; 2: 189-95
16. Fisher RA, Kulik LM, Freise CE et al: Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant, 2007; 7: 1601-8
17. Zieniewicz K, Patkowski W, Nyckowski P et al: Results of liver transplantation for hepatocellular cancer. Ann Transplant, 2007; 12: 11-14
18. Mangus RS, Fridell JA, Vianna RM et al: Use of the piggyback hepatectomy technique in liver transplant recipients with hepatocellular carcinoma. Transplantation, 2008; 85: 1496-99
19. Axelrod DA, Guidinger MK, McCullough KP et al: Association of center volume with outcome after liver and kidney transplantation. Am J Transplant, 2004; 4: 920-27
20. Majeed TA, Wai CT, Rajekar H et al: Experience of the transplant team is an important factor for posttransplant survival in patients with hepatocellular carcinoma undergoing livingdonor liver transplantation. Transplant Proc, 2008; 40: 2507-9
21. Harada N, Shirabe K, Ikeda Y et al: Surgical management of hepatocellular carcinoma in Child-Pugh class B cirrhotic patients: hepatic resection and/or microwave coagulation therapy versus living donor liver transplantation. Ann Transplant, 2012; 17: 11-20
22. Chan EY, Larson AM, Fix OK et al: Identifying risk for recurrent hepatocellular carcinoma after liver transplantation: implications for surveillance studies and new adjuvant therapies. Liver Transpl, 2008; 14: 956-65
23. Hemming AW, Cattral MS, Reed AI et al: Liver transplantation for hepatocellular carcinoma. Ann Surg, 2001; 233: 652-59
24. Parfitt JR, Marotta P, Alghamdi M et al: Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence. Liver Transpl, 2007; 13: 543-51
25. Li C, Wen TF, Liao ZX et al: Recurrence of hepatocellular carcinoma after liver transplantation: recurrence characteristics and risk factors. Hepatogastroenterology, 2010; 57: 567-70
26. Alvite-Canosa M, Pita-Fernández S, Quintela-Fandiño J et al: Prognostic and developmental factors in patients receiving liver transplant due to hepatocellular carcinoma: one center's experience in the north of Spain. Transplant Proc, 2010; 42: 4578-81
27. Bharat A, Brown DB, Crippin JS et al: Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. J Am Coll Surg, 2006; 203: 411-20
28. Levi DM, Tzakis AG, Martin P et al: Liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease era. J Am Coll Surg, 2010; 210: 727-36
29. Gra{ogonek}t M, Hołówko W, Grzegorczyk K et al: Longterm results of liver resection in the treatment of patients with hepatocellular carcinoma. Pol Przegl Chir, 2011; 83: 319-24
30. Mazzaferro V, Regalia E, Doci R et al: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med, 1996; 334: 693-99
31. Bradburn MJ, Clark TG, Love SB, Altman DG: Survival Analysis Part III: Multivariate data analysis-choosing a model and assessing its adequacy and fit. Br J Cancer, 2003; 89: 605-11
32. Hilmi IA, Planinsic RM: Con: venovenous bypass should not be used in orthotopic liver transplantation. J Cardiothorac Vasc Anesth, 2006; 20: 744-47
33. Akbas H, Erdal AC, Demiralp E, Alp M: Effects of coronary artery bypass grafting on cellular immunity with or without cardiopulmonary bypass: changes in lymphocytes subsets. Cardiovasc Surg, 2002; 10: 586-89
34. Yamamoto S, Yoshimasu T, Nishimura Y et al: In vitro evaluation of the effect of cardiac surgery on cancer cell proliferation. Ann Thorac Cardiovasc Surg, 2011; 17: 260-66
35. Platell C: Influence of cardiopulmonary bypass surgery on cancer-specific survival rate of patients with colorectal cancer. Dis Colon Rectum, 1998; 41: 1371-75
36. Darwazah AK, Shehata S: Detrimental effect of cardiopulmonary bypass (CPB) on malignant disease. J Cardiothorac Surg, 2011; 6: 13
37. Tanaka H, Narisawa T, Hirano J et al: Efficacy of off-pump coronary artery bypass grafting in patients requiring noncardiac operations. Kyobu Geka, 2001; 54: 1107-11
38. Ghobrial RM, Gornbein J, Steadman R et al: Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg, 2002; 236: 315-22
39. de Boer MT, Christensen MC, Asmussen M et al: The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg, 2008; 106: 32-44
40. Nishida S, Nakamura N, Vaidya A et al: Piggyback technique in adult orthotopic liver transplantation: an analysis of 1067 liver transplants at a single center. HPB (Oxford), 2006; 8: 182-88
41. Ku Y, Kusunoki N, Shiotani M et al: Stimulation of Haematogenous Liver Metastases by Ischaemia-Reperfusion in Rats. Eur J Surg, 1999; 165: 801-7
42. Doi K, Horiuchi T, Uchinami M et al: Hepatic ischemia-reperfusion promotes liver metastasis of colon cancer. J Surg Res, 2002; 105: 243-47
43. van der Bilt JD, Kranenburg O, Nijkamp MW et al: Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model. Hepatology, 2005; 42: 165-75
44. Fan ST, Yang ZF, Ho DW et al: Prediction of posthepatectomy recurrence of hepatocellular carcinoma by circulating cancer stem cells: a prospective study. Ann Surg, 2011; 254: 569-76
45. Aguirre-Ghiso JA: Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer, 2007; 7: 834-46
46. Ghio M, Contini P, Negrini S et al: Down regulation of human natural killer cell-mediated cytolysis induced by blood transfusion: role of transforming growth factor-{b(1), soluble Fas ligand, and soluble Class I human leukocyte antigen. Transfusion, 2011; 51: 1567-73
47. Waldhauer I, Steinle A: NK cells and cancer immunosurveillance. Oncogene, 2008; 27: 5932-43
48. Wang CC, Iyer SG, Low JK et al: Perioperative factors affecting long-term outcomes of 473 consecutive patients undergoing hepatectomy for hepatocellular carcinoma. Ann Surg Oncol, 2009; 16: 1832-42
49. Hanazaki K, Kajikawa S, Shimozawa N et al: Perioperative blood transfusion and survival following curative hepatic resection for hepatocellular carcinoma. Hepatogastroenterology, 2005; 52: 524-29
50. Shiba H, Ishida Y, Wakiyama S et al: Negative impact of blood transfusion on recurrence and prognosis of hepatocellular carcinoma after hepatic resection. J Gastrointest Surg, 2009; 13: 1636-42
51. Dahiya D, Wu TJ, Lee CF et al: Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience. Surgery, 2010; 147: 676-85
52. Lo CM, Fan ST, Liu CL et al: Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg, 2007; 94: 78-86
53. Bhangui P, Vibert E, Majno P et al: Intention-totreat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation. Hepatology, 2011; 53: 1570-79